Itch which is one of the major, subjective symptoms in a course of bullous pemphigoid and dermatitis herpetiformis makes those two diseases totally different than other autoimmune blistering diseases. Its pathogenesis is still not fully known. The aim of this research was to assess the role of IL-31 in development of itch as well as to measure its intensity. Obtained results, as well as literature data, show that lower concentration of IL-31 in patients' serum may be correlated with its role in JAK/STAT signaling pathway which is involved in development of autoimmune blistering disease. Intensity of itch is surprisingly huge problem for the patients and the obtained results are comparable with results presented by atopic patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541788PMC
http://dx.doi.org/10.1155/2017/5965492DOI Listing

Publication Analysis

Top Keywords

course bullous
8
bullous pemphigoid
8
pemphigoid dermatitis
8
dermatitis herpetiformis
8
autoimmune blistering
8
role intereukin-31
4
intereukin-31 pathogenesis
4
itch
4
pathogenesis itch
4
itch intensity
4

Similar Publications

Bullous pemphigoid (BP) is the most prevalent autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and manifests with pruritus and localized or, most commonly, generalized bullous lesions. Numerous studies have established the association between BP and oral antidiabetic agents, particularly dipeptidyl peptidase 4 (DPP4) inhibitors, diuretics, and certain antibiotics, notably levofloxacin and cephalexin.

View Article and Find Full Text PDF

Linear IgA bullous dermatosis: 32 years of experience.

An Bras Dermatol

December 2024

Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.

Background: Linear IgA bullous dermatosis (LABD) is an uncommon disease with only a few reported studies in large series with long follow-up periods.

Objectives: To evaluate the clinical presentation, immunopathological features, management, and disease course in LABD patients.

Methods: Data including demographics, clinical features, histopathological and immunofluorescence findings of LABD patients, in addition to the preferred treatments and responses to treatments were evaluated.

View Article and Find Full Text PDF

Background: Systemic Lupus Erythematosus (SLE) (C1) is a disease with multi-organ involvement that can have a variety of cutaneous manifestations in 76% of cases during the disease. Less than 1% of these patients are diagnosed with confirmed bullous systemic lupus erythematosus (C1). Given the wide differential diagnosis of a bullous lesion, it is imperative to reach a conclusive diagnosis as it can have a direct impact on the course of management of the disease.

View Article and Find Full Text PDF
Article Synopsis
  • Bullous emphysema is a chronic lung disease marked by the presence of large air spaces called bullae, with giant bullae being particularly significant and often requiring surgical removal known as bullectomy.
  • A 35-year-old man with a history of COVID-19 experienced chest pain and difficulty breathing, leading to the discovery of a giant bulla in his left lung on imaging scans.
  • Remarkably, after monitoring over several months, the giant bulla spontaneously resolved without surgery, suggesting that infectious processes may play a role in this phenomenon, highlighting the importance of careful imaging and follow-up in similar cases.
View Article and Find Full Text PDF

Gestational pemphigoid is a rare, autoimmune, subepidermal bullous disease with an incidence of 1 in 50,000 pregnancies, displaying itself through pruritic erythema and urticarial papules and plaques that evolve into tense bullae. Histopathological findings consist of subepidermal vesicles with perivascular eosinophils and lymphocytes, and direct immunofluorescence reveals C3 complement and, more rarely, IgG in a linear band along the basement membrane. The course is usually self-limiting within 6 months after delivery but, later, can be triggered by subsequent pregnancies, menstruation, or treatment with oral contraceptives.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!